当前位置:首页 - 行情中心 - 贝达药业(300558) - 财务分析 - 资产负债表

贝达药业

(300558)

  

流通市值:212.60亿  总市值:213.26亿
流通股本:4.17亿   总股本:4.18亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金595,341,383.28464,904,786.45554,020,499.69751,996,914.5
应收票据及应收账款228,298,781.64210,892,921.63207,417,494.2286,410,358.38
应收账款228,298,781.64210,892,921.63207,417,494.2286,410,358.38
预付款项20,248,027.7417,932,117.0833,123,76516,436,903.49
其他应收款合计1,774,075.351,756,804.673,558,388.322,609,605.58
存货289,085,227.67325,102,809.5336,995,087.7327,501,767.43
其他流动资产170,776,990.84163,448,198.18155,866,700.7140,385,572.08
流动资产平衡项目0000
流动资产合计1,526,566,689.451,184,580,501.761,291,522,377.581,525,880,626.51
非流动资产:
长期股权投资368,815,545.01370,526,548.22373,058,191.24375,210,221.24
其他权益工具投资986,987,432.521,190,654,307.591,322,398,591.991,006,597,002.32
投资性房地产31,955,070.8332,564,653.733,174,236.5733,783,819.44
固定资产500,348,438.58524,930,720.02498,858,248.15524,363,656.99
在建工程2,328,571,008.912,174,352,080.652,122,025,292.92,036,585,745.95
使用权资产8,045,277.719,407,690.0612,059,636.2613,127,213.53
无形资产1,782,827,501.141,851,465,998.771,910,307,539.031,943,510,385.64
开发支出1,370,653,376.161,350,147,318.841,276,827,316.971,218,618,697.97
商誉413,584,000.09413,584,000.09413,584,000.09413,584,000.09
递延所得税资产38,936,666.6439,006,059.3571,767,740.7139,129,091.16
其他非流动资产681,062.39664,562.39876,887.3916,517,934.69
非流动资产平衡项目0000
非流动资产合计7,831,405,379.987,957,303,939.688,034,937,681.37,621,027,769.02
资产平衡项目0000
资产总计9,357,972,069.439,141,884,441.449,326,460,058.889,146,908,395.53
流动负债:
短期借款111,083,600150,091,563.89180,350,489.31300,267,112.23
交易性金融负债10,000,00010,000,00010,000,00010,000,000
应付票据及应付账款712,526,398.91668,997,872.07672,075,735.34800,118,473.86
应付账款712,526,398.91668,997,872.07672,075,735.34800,118,473.86
预收款项4,475,684.381,024,605.722,136,485.53888,436.41
合同负债1,751,021.77481,477.99943,913.224,034,968.51
应付职工薪酬133,377,406.34117,272,769.64118,759,727.52149,451,198.84
应交税费16,370,277.1922,471,109.2415,453,703.7111,913,468.68
其他应付款合计217,102,184.8200,306,072.88192,466,392.03217,436,716.51
一年内到期的非流动负债565,963,655516,869,123.37224,816,944.74305,856,408.81
其他流动负债4,247,239.753,736,391.723,325,071.333,190,083.18
流动负债平衡项目0000
流动负债合计1,776,897,468.141,691,250,986.521,420,328,462.731,803,156,867.03
非流动负债:
长期借款1,645,490,0001,680,490,0002,074,490,0001,816,000,000
租赁负债6,135,678.576,943,724.757,338,773.488,182,841.02
递延收益154,308,516.08142,375,599.8142,006,016.85144,703,100.57
递延所得税负债49,029,128.5756,686,920.3469,456,873.2523,391,928.11
非流动负债平衡项目0000
非流动负债合计1,854,963,323.221,886,496,244.892,293,291,663.581,992,277,869.7
负债平衡项目0000
负债合计3,631,860,791.363,577,747,231.413,713,620,126.313,795,434,736.73
所有者权益(或股东权益):
实收资本(或股本)418,485,885418,485,885418,485,885418,485,885
资本公积2,214,572,460.92,194,876,687.032,167,100,550.912,141,636,415.27
其他综合收益156,150,664.1202,849,556.35335,789,961.93188,296,793.71
盈余公积209,437,194.65209,437,194.65209,437,194.65209,437,194.65
未分配利润2,638,304,094.242,446,026,001.912,391,361,534.832,293,220,793.27
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计5,636,950,298.895,471,675,324.945,522,175,127.325,251,077,081.9
少数股东权益89,160,979.1892,461,885.0990,664,805.25100,396,576.9
股东权益平衡项目0000
股东权益合计5,726,111,278.075,564,137,210.035,612,839,932.575,351,473,658.8
负债和股东权益合计9,357,972,069.439,141,884,441.449,326,460,058.889,146,908,395.53
公告日期2024-10-292024-08-062024-04-202024-04-20
审计意见(境内)标准无保留意见
TOP↑